Abstract
Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of Coccidioides posadasii or C. immitis. This neglected disease occurs in the desert areas of the western United States, most notably in California and Arizona, where infections continue to rise. Clinically, coccidioidomycosis ranges from asymptomatic to severe pulmonary disease and can disseminate to the brain, skin, bones, and elsewhere. New estimates suggest as many as 350,000 new cases of coccidioidomycosis occur in the United States each year. Thus, there is an urgent need for the development of a vaccine and new therapeutic drugs against Coccidioides infection. In this review, we discuss the battle against Coccidioides including the development of potential vaccines, the quest for new therapeutic drugs, and our current understanding of the protective host immune response to Coccidioides infection.
Original language | English (US) |
---|---|
Article number | 2188 |
Journal | Frontiers in Immunology |
Volume | 10 |
DOIs | |
State | Published - Sep 11 2019 |
Keywords
- Coccidioides
- antifungal drugs
- fungal vaccines
- immunity
- valley fever
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology